FRI0113 Validation and Results of the Symptoms in Persons at Risk of Rheumatoid Arthritis (SPARRA) Questionnaire

doi 10.1136/annrheumdis-2017-eular.2450
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Follow-Up Standards and Treatment Targets in Rheumatoid Arthritis: Results of a Questionnaire at the EULAR 2008

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2009English

Assessment of Self-Injection Experience in Patients With Rheumatoid Arthritis: Psychometric Validation of the Self-Injection Assessment Questionnaire (SIAQ)

Health and Quality of Life Outcomes
MedicineEnvironmentalPublic HealthOccupational Health
2011English

Regional Differences Regarding Risk of Developing Rheumatoid Arthritis in Stockholm County, Sweden: Results From the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) Study

Scandinavian Journal of Rheumatology
MedicineRheumatologyAllergyImmunology
2013English

Serum Bilirubin and the Risk of Rheumatoid Arthritis

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2017English

Immunosuppressive Treatment and the Risk of Diabetes in Rheumatoid Arthritis

PLoS ONE
Multidisciplinary
2019English

Late Results of Gold Treatment in Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1952English

Two Independent Alleles at 6q23 Associated With Risk of Rheumatoid Arthritis

Nature Genetics
Genetics
2007English

Validation of Rheumatoid Arthritis Diagnoses in Health Care Utilization Data

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2011English

P023 Tenosynovitis and HLA-SE Predict Arthritis Onset in ACPA-positive Individuals at Risk of Developing Rheumatoid Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy